PATENT CLAIM ANALYSIS

Application Number: 16218341
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["540", "602000"]

Abstract:
Methods for treating a tumor, such as a benign or malignant tumor, are disclosed herein. The methods include administering a therapeutically effective amount of a small molecule that selectively binds to and stabilizes G-quadruplex DNA in the promoter of the c-MYC gene to the subject. The methods are also of use to decrease the size and/or number of metastases. Compounds for use in the disclosed methods are also provided.

Claim (Index 29):
The method of  claim 28 , wherein the anticancer agent is a proteasome inhibitor.

Metadata:
- Claim Count in Document: 80.0
- Percentile: 98.0
- Lexical Diversity: 1.5625
- Patent Class: 540.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15541676', '13513819', '13991321', '14156314', '14571647']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7023145592951417
- 35 USC 102 Novelty (BERT): 0.5792096128405076
- Combined Prediction Score: 0.6900040646496783
- Mean Citation Score: 316.660638
- Max Citation Score: 528.7619599999998
- Similarity Product: 335.44640366921413

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test